The insider selling is immaterial in dollar terms and does not suggest a bearish signal. Monitor for any larger-scale insider transactions in the coming weeks, but this cluster alone warrants no action. The mixed earnings report remains the more relevant near-term catalyst.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 10 $36.14entry
- T+1 · 3mo ago +0.94%α +1.26% · $36.48
- T+5 · 3mo ago +0.89%α +0.93% · $36.46
- T+20 · 2mo ago +1.72%α +2.63% · $36.76
- T+60 · 14d ago +15.97%α +18.38% · $41.91
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Teva insiders sold a combined $1.34M in shares over the past week, representing 0.003% of the $41.2B market cap, a trivial amount. The sales occurred shortly after Teva's Q2 earnings release (mixed results: revenue -1% YoY, EPS miss, but strong innovative brand growth and maintained guidance). The dollar value is too small to carry any informational signal.
Key Financial Metrics
Key Facts
- Three insiders sold shares: Eric A. Hughes (25.6K shares, $892K), Placid Jover (12.8K shares, $447K), and Tal Zvi Zaks (17 shares, $593)
- Total selling value of $1.34M is 0.003% of Teva's $41.2B market cap
- Sales occurred on 2026-08-03 and 2026-08-05, following the Q2 2026 earnings release on 2026-07-29
- Q2 earnings showed revenue of $4.14B (-1% YoY) and non-GAAP EPS of $0.02, below consensus of $0.05
Financial Impact
Insider selling of $1.34M is negligible relative to market cap of $41.2B (<0.01%)
Risk Factors
- No material risk from this cluster due to negligible dollar amounts
- If insiders increase selling volume significantly, it could signal a change in sentiment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TEVA-1786356496894 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $44.50 +3.10% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $44.50 +1.95% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $44.50 +2.91% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $44.50 +4.44% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers